UNIL088 is a water-soluble prodrug of cyclosporine A (CsA) developed for topical eye delivery. Such a prodrug has to fulfil two paradoxical requirements as it must be rapidly hydrolysed under physiological conditions but also retain a long shelf-life in aqueous media. This study has been conducted to explore the stability of UNIL088 formulated as an eyedrop solution. The stability study of the prodrug was performed over a pH range of 5–7 at 20 °C and at various ionic strengths. The molecule was more stable at pH 5 than at pH 7 with conversion rate constant of 3.2 × 10^−3 and 26.0 × 10^−3 days^−1, respectively. The effect of temperature was studied at four different temperatures and activation energy was determined. Conversion of UNIL088 followed a pseudo-first-order kinetic with an activation energy of 79.4 kJ mol^−1. Due to its low solubility, CsA generated precipitated in the solution. The average size of CsA precipitates, determined by photon spectroscopy, was 0.22 and 1.08 μm at 7 and 14 days, respectively. The hydrolysis mechanism was partially elucidated by identification of the intermediate pSer-Sar-CsA.

Electron paramagnetic resonance (EPR) imaging was applied to investigate further the in vitro degradation process of poly(ortho esters) containing 30 mol % lactic acid units in the polymer backbone (POE₇₀LA₃₀) and developed for controlled drug delivery. The objective of this study was the direct and continuous determination of pH values inside the degrading POE₇₀LA₃₀. pH-sensitive nitroxide spin probes 4-amino-2,2,5,5-tetramethyl-3-imidazoline-1-yloxy, 2,2,3,4,5,5-hexamethylimidazolidine-1-yloxy, and 2,2,4,5,5-pentamethyl-3-imidazoline-1-yloxy were calibrated in buffer solutions in order to cover a pH range between 1.0 and 8.0. Nitroxide spin probes were incorporated in POE₇₀LA₃₀, and polymer samples were incubated in 0.1 M phosphate buffer (pH 7.4) at 37 °C. At selected times, polymer samples were removed for the determination of pH values inside the eroding POE₇₀LA₃₀ by EPR at a frequency of 9.4 GHz. EPR imaging showed that the in vitro degradation of POE₇₀LA₃₀ followed a two-phase process:  in the first week of incubation, diffusion of water, and in consequence polymer degradation, were limited to the surface of the hydrophobic POE₇₀LA₃₀ where pH values between 6.0 and 7.4 were measured. After 1 week of incubation, water diffused into the core of the sample, allowing the determination of pH values inside the eroding POE₇₀LA₃₀ until complete erosion. Results indicated the formation of a pH gradient, with the most acidic environment inside the eroding sample where the lowest pH value of 3.8 was measured and higher pH at the surface. It was also possible to observe a polymer erosion front moving down within the polymer matrix in the course of time. The pH value of 3.8 measured inside the degrading POE₇₀LA₃₀ remained constant until polymer samples disintegrated at day 23, where no EPR signal was detectable. In conclusion, EPR imaging allows the noninvasive spatially resolved observation of pH changes within POE₇₀LA₃₀, and results confirmed that the in vitro erosion mechanism of POE₇₀LA₃₀ was neither bulk erosion nor pure surface erosion.

Polylactic acid (PLA) is a biocompatible and biodegradable material with wide utility for many applications, including the design of controlled-release systems for pharmaceutical agents. The factors determining the degradation kinetics of these systems include the composition and the molecular mass of the polymer, the morphology and the structure of the device, and the influence of thermal processes. The processing of the polymer determines the structure and design of the device, and influences to a high degree its morphology, namely its microporous structure, polymeric chain orientation and crystallinity. In this work, we aimed to compare the influence of two different implant manufacturing techniques, extrusion and injection-molding, on the in vitro degradation of the polymeric matrix. Both kinds of implants were loaded with a somatostatin analogue. Decrease in molecular weight, and polydispersity evolution during an accelerated in vitro degradation test were studied by size exclusion chromatography. Morphological changes in the polymeric matrix during degradation were followed after defined time intervals by means of scanning electron microscopy. Crystallinity studies were performed by differential scanning calorimetry and by X-ray analysis. Peptide stability in the polymeric matrix after both manufacturing methods was evaluated. Peptide release profiles, obtained in vitro during a week dissolution test, from both implant samples, were studied. It was shown that both molecular weight and polydispersity decreased after extrusion or injection-molding. This decrease was more pronounced with the latter technique. Crystallinity studies demonstrated that the crystalline network was not destroyed after both manufacturing methods. Peptide release profiles obtained in vitro were in good accordance with scanning electron microscopy. It was found that both manufacturing techniques had to be considered, although the extruded implants degraded more rapidly in vitro than the injection-molded ones.